Physician profile
Ty Richardson
NPI 1881685444
$2,711.14
in general payments reported to CMS, 2019-2025
25 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $712 · 2020: $36.54 · 2021: $122 · 2022: $251 · 2023: $938 · 2024: $493 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,307 · Education: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,307.37 |
| Education | $282.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $575.64 | 2023-2024 | |
| Zimmer Biomet Holdings, INC. | $447.43 | 2023 | Comprehensive Shoulder System, Speedsnare, Juggerknotless Soft Anchor |
| Linvatec Corporation | $424.46 | 2019-2021 | |
| Encore Medical, Lp | $282.84 | 2019-2022 | |
| Stryker Corporation | $178.32 | 2019-2023 | Blueprint Patient Specific Instrumentation |
| Exactech, INC. | $135.46 | 2024 | |
| Miach Orthopaedics, INC. | $120.79 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $85.49 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $58.18 | 2022 | |
| Ferring Pharmaceuticals INC. | $49.98 | 2019-2020 | |
| Smith+Nephew, INC. | $44.74 | 2024 | Grafix, Stravix, Oasis |
| Pacira Pharmaceuticals Incorporated | $43.88 | 2022-2023 | Exparel, Iovera, Zilretta |
| Amgen INC. | $37.83 | 2023-2025 | Krystexxa, Prolia, Evenity |
| Shoulder Innovations, INC. | $36.91 | 2025 | Inset System |
| Ethicon US, LLC | $26.15 | 2019-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medartis INC. | $24.09 | 2020 | |
| Next Science LLC | $23.67 | 2023 | Surgx, Blastx, Xperience |
| Nestle Healthcare Nutrition INC. | $16.65 | 2022 | |
| Pacira Therapeutics, INC. | $16.60 | 2021 | |
| Blue Surgical LLC | $16.45 | 2025 | |
| Abbvie INC. | $15.15 | 2021 | |
| Heron Therapeutics, INC. | $14.32 | 2023 | Zynrelef |
| Vericel Corporation | $14.06 | 2022 | |
| Nevro Corp. | $13.16 | 2023 | Senza |
| Orthofix Medical, INC. | $8.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ty Richardson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.